MicroWorld eScan Management Console 14.0.1400.2281 Edit User Form from cross site scripting
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 7.1 | $0-$5k | 0.00 |
Summary
A vulnerability identified as problematic has been detected in MicroWorld eScan Management Console 14.0.1400.2281. This affects an unknown function of the component Edit User Form. The manipulation of the argument from leads to cross site scripting. This vulnerability is traded as CVE-2023-31703. It is possible to initiate the attack remotely. Furthermore, there is an exploit available.
Details
A vulnerability, which was classified as problematic, has been found in MicroWorld eScan Management Console 14.0.1400.2281. This issue affects some unknown functionality of the component Edit User Form. The manipulation of the argument from with an unknown input leads to a cross site scripting vulnerability. Using CWE to declare the problem leads to CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. Impacted is integrity. The summary by CVE is:
Cross Site Scripting (XSS) in the edit user form in Microworld Technologies eScan management console 14.0.1400.2281 allows remote attacker to inject arbitrary code via the from parameter.
The weakness was shared 05/17/2023. It is possible to read the advisory at github.com. The identification of this vulnerability is CVE-2023-31703 since 04/29/2023. It demands that the victim is doing some kind of user interaction. Technical details as well as a public exploit are known. The attack technique deployed by this issue is T1059.007 according to MITRE ATT&CK.
The exploit is available at exploit-db.com. It is declared as proof-of-concept.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
The vulnerability is also documented in the databases at Exploit-DB (51467) and EUVD (EUVD-2023-35998). Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.
Product
Vendor
Name
Version
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 7.2VulDB Meta Temp Score: 7.1
VulDB Base Score: 3.5
VulDB Temp Score: 3.2
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 9.0
NVD Vector: 🔍
CNA Base Score: 9.0
CNA Vector: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Access: Public
Status: Proof-of-Concept
Download: 🔍
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Exploit-DB: 🔍
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
04/29/2023 🔍05/17/2023 🔍
05/17/2023 🔍
12/28/2025 🔍
Sources
Advisory: 172540Status: Not defined
CVE: CVE-2023-31703 (🔍)
GCVE (CVE): GCVE-0-2023-31703
GCVE (VulDB): GCVE-100-229259
EUVD: 🔍
scip Labs: https://www.scip.ch/en/?labs.20161013
Entry
Created: 05/17/2023 16:34Updated: 12/28/2025 02:27
Changes: 05/17/2023 16:34 (39), 06/10/2023 10:00 (1), 06/10/2023 10:02 (11), 01/06/2025 01:46 (24), 01/22/2025 21:18 (11), 04/26/2025 15:56 (3), 12/28/2025 02:27 (1)
Complete: 🔍
Cache ID: 216::103
Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.